Myeloid leukemia factor 1: A "double-edged sword" in health and disease.

导出 LinkOut

翻译打印收藏纠错

第一作者： Zixuan,Li

第一单位： Department of Hematology, the First Affiliated Hospital of Kunming Medical University, Kunming, China.

作者： Zixuan,Li ^[1] ; Yuanyuan,Yang ^[2] ; Kun,Wu ^[1] ; Yuntao,Li ^[2] ; Mingxia,Shi ^[3]

作者单位： Department of Hematology, the First Affiliated Hospital of Kunming Medical University, Kunming, China. ^[1] Hematology Research Center of Yunnan Province, Kunming, China. ^[2] Department of Clinical Laboratory, First Affiliated Hospital of Kunming Medical University, Kunming, China. ^[3]

关键词 cell cycle regulation cell development and differentiation immune function malignancy development myeloid leukemia factor 1 nucleo-cytoplasmic shuttling protein

DOI 10.3389/fonc.2023.1124978

PMID 36814822

发布时间 2023-02-24

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Frontiers in oncology

2023年13卷

1124978页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Myeloid leukemia factor 1: A "double-edged sword" in health and disease.

Frontiers in oncology

相似文献

Frontiers in oncology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Myeloid leukemia factor 1: A "double-edged sword" in health and disease.

Frontiers in oncology

相似文献

Frontiers in oncology

相关期刊

检索历史清除